Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.

BACKGROUND: Blood pressure is an important determinant of the risks of macrovascular and microvascular complications of type 2 diabetes, and guidelines recommend intensive lowering of blood pressure for diabetic patients with hypertension. We assessed the effects of the routine administration of an...

Full description

Bibliographic Details
Main Authors:	Patel, A, MacMahon, S, Chalmers, J, Neal, B, Woodward, M, Billot, L, Harrap, S, Poulter, N, Marre, M, Cooper, M, Glasziou, P, Grobbee, D, Hamet, P, Heller, S, Liu, L, Mancia, G, Mogensen, C, Pan, C, Rodgers, A, Williams, B
Format:	Journal article
Language:	English
Published:	2007

Similar Items

Combined effects of routine blood pressure lowering and intensive glucose control on macrovascular and microvascular outcomes in patients with type 2 diabetes: New results from the ADVANCE trial.
by: Zoungas, S, et al.
Published: (2009)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
by: Mohammedi, K, et al.
Published: (2017)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: the ADVANCE trial.
by: Hata, J, et al.
Published: (2013)

Effects of visit-to-visit variability in systolic blood pressure on macrovascular and microvascular complications in patients with type 2 diabetes mellitus: The advance trial
by: Hata, J, et al.
Published: (2013)

Microvascular and macrovascular disease and risk for major peripheral arterial disease in patients with type 2 diabetes
by: Woodward, M, et al.
Published: (2016)

Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
by: Kamel Mohammedi, et al.
Published: (2017-07-01)

Cost-effectiveness of lowering blood pressure with a fixed combination of perindopril and indapamide in type 2 diabetes mellitus: an ADVANCE trial-based analysis.
by: Glasziou, P, et al.
Published: (2010)

Circulating amino acids and the risk of macrovascular, microvascular and mortality outcomes in individuals with type 2 diabetes: results from the ADVANCE trial
by: Welsh, P, et al.
Published: (2018)

Which health-related quality of life score? A comparison of alternative utility measures in patients with Type 2 diabetes in the ADVANCE trial
by: Glasziou, P, et al.
Published: (2007)

Visit-to-visit Variability of Systolic Blood Pressure Predicts Macrovascular and Microvascular Events in Patients with Type 2 Diabetes: the ADVANCE Trial
by: Hata, J, et al.
Published: (2012)

Potential pharmacokinetic interactions in fixed-dose combinations of perindopril/indapamide/amlodipine compared with perindopril/indapamide and amlodipine in healthy Chinese volunteers
by: Huitao Gao, et al.
Published: (2023-03-01)

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
by: Patel, A, et al.
Published: (2008)

Acute increases in serum creatinine after starting angiotensin-converting enzyme inhibitor-based therapy and effects of its continuation on major clinical outcomes in type 2 diabetes mellitus: the ADVANCE trial
by: Ohkuma, T, et al.
Published: (2018)

Effects of Perindopril-Based Lowering of Blood Pressure on Intracerebral Hemorrhage Related to Amyloid Angiopathy: The PROGRESS Trial
by: Arima, H, et al.
Published: (2010)

Perindopril-based blood pressure lowering reduces major vascular events in Asian and Western participants with cerebrovascular disease: the PROGRESS trial
by: Arima, H, et al.
Published: (2010)

Side-effects and tolerability of combination blood pressure lowering according to blood pressure levels – an analysis of the PROGRESS and ADVANCE trials
by: Atkins, A, et al.
Published: (2017)

USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA
by: O. M. Drapkina, et al.
Published: (2017-09-01)

Lowering blood pressure reduces renal events in type 2 diabetes.
by: de Galan, B, et al.
Published: (2009)

Low-dose combination of perindopril arginine with indapamide in correction of metabolic syndrome
by: Svetlana Igorevna Kseneva, et al.
Published: (2011-10-01)

Influence of fixed combination perindopril and indapamide on heart and vascular remodeling in hypertensive patients
by: Yu. M. Lopatin, et al.
Published: (2005-02-01)

Blood pressure normalization in a large population of hypertensive patients treated with perindopril/indapamide combination: results of the OPTIMAX trial
by: Jean-Jacques Mourad, et al.
Published: (2007-03-01)

Fracture risk and the use of a diuretic (indapamide sr) ± perindopril: a substudy of the Hypertension in the Very Elderly Trial (HYVET)
by: Thijs Lutgarde, et al.
Published: (2006-12-01)

Self‐rated health scores predict mortality among people with type 2 diabetes differently across three different country groupings: findings from the ADVANCE and ADVANCE‐ON trials
by: Hua, X, et al.
Published: (2020)

Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus: the ADVANCE trial
by: Rahman, F, et al.
Published: (2019)

Combination of perindopril/indapamide in secondary prevention of stroke and other vascular events: A combined analysis of ADVANCE, PROGRESS and HYVET trials
by: Sougat Sourendra Sarkar
Published: (2011-07-01)

History of lower-limb complications and risk of cancer death in people with type 2 diabetes
by: Kamel Mohammedi, et al.
Published: (2021-01-01)

Blood pressure variables and cardiovascular risk: new findings from ADVANCE.
by: Kengne, A, et al.
Published: (2009)

CHRONIC KIDNEY DISEASE AND CEREBROCARDIOVASCULAR COMPLICATIONS IN ARTERIAL HYPERTENSION: RESULTS OF PERINDOPRIL А USAGE WITH INDAPAMID
by: V. G. Shemetova, et al.
Published: (2014-08-01)

CLINICAL EFFICACY OF COMBINATION THERAPY WITH PERINDOPRIL AND INDAPAMIDE IN PATIENTS WITH MILD AND MODERATE ARTERIAL HYPERTENSION
by: G. J. Abdullayeva, et al.
Published: (2016-03-01)

Estimating individual beneficial and adverse effects of intensive glucose control for patients with type 2 diabetes
by: Woodward, M, et al.
Published: (2016)

Two case reports: clinical experience with fixed combinations of indapamide/perindopril and amlodipine/perindopril in patients with arterial hypertension during the COVID-19 pandemic
by: S. Ia. Tazina, et al.
Published: (2022-05-01)

Efficacy, safety of combined perindopril and indapamide low-dose therapy in patients with arterial hypertension and metabolic syndrome
by: O. N. Andreeva, et al.
Published: (2005-06-01)

Fixed-dose combination of perindopril and indapamide: perspectives in hypertensive patients with inadequately controlled blood pressure
by: I. E. Chazova, et al.
Published: (2007-02-01)

Validation of a dissolution method with RP-HPLC analysis for Perindopril erbumine and Indapamide combination tablet
by: Jain P.S., et al.
Published: (2012-01-01)

PERINDOPRIL/INDAPAMIDE FIXED COMBINATION AND REGRESSION OF TARGET ORGAN DAMAGE: ACTING THROUGH MACRO AND MICROCIRCULATION
by: Bernard I. Lévy
Published: (2019-12-01)

Effectiveness of combination of perindopril and indapamide on ambulatory arterial stiffness index in Vietnamese patients with primary hypertension
by: Son Kim Tran, et al.
Published: (2022-09-01)

Effects of Blood Pressure Lowering on Major Vascular Events Among Patients With Isolated Diastolic Hypertension: The Perindopril Protection Against Recurrent Stroke Study (PROGRESS) Trial
by: Arima, H, et al.
Published: (2011)

ADVANTAGES AND NOVELTY OF CLINICAL APPLICATION OF THE TRIPLE COMBINATION FOR ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA: ACE INHIBITOR PERINDOPRIL WITH ROSUVASTATIN AND INDAPAMIDE
by: M. L. Maksimov, et al.
Published: (2017-08-01)

The comparative analysis of therapy by «typical practice» and the fixed combination perindopril and indapamide an arterial hypertension with kidney insufficiency
by: S V Shiganov, et al.
Published: (2013-12-01)

Use of the waist‐to‐height ratio to predict cardiovascular risk in patients with diabetes: Results from the ADVANCE‐ON study
by: Rådholm, K, et al.
Published: (2018)